PE Anti-P Glycoprotein antibody [UIC2]
Be the first to review this product! Submit a review
|
(11 Publications)
Mouse Monoclonal P Glycoprotein antibody - conjugated to PE. Suitable for Flow Cyt and reacts with Human samples. Cited in 11 publications. Immunogen corresponding to Cell preparation containing ABCB1 protein.
View Alternative Names
CD243, MDR1, PGY1, ABCB1, ATP-dependent translocase ABCB1, ATP-binding cassette sub-family B member 1, Multidrug resistance protein 1, P-glycoprotein 1, Phospholipid transporter ABCB1
- Flow Cyt
Unknown
Flow Cytometry - PE Anti-P Glycoprotein antibody [UIC2] (AB93590)
Staining of the human 8226/S (blue histogram) and human 8226 DOX40 (purple histogram) cell lines with PE Mouse IgG2a, K Isotype Control (left) or ab93590 (right). Total viable cells were used for analysis.
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
P-glycoprotein acts as a protective mechanism against toxic substances and drugs within the body. It is a member of the ATP-binding cassette (ABC) transporter family which is critical for their ability to transport molecules across membranes. P-glycoprotein is not typically part of a larger protein complex but can interact with other membrane proteins to facilitate its function. Its role in drug metabolism and excretion is vital for maintaining the balance and elimination of harmful substances.
Pathways
P-glycoprotein plays a significant role in the pharmacokinetics of drugs within the body. This transporter is involved in the multi-drug resistance (MDR) pathway which impacts the efficacy of chemotherapeutic agents. P-glycoprotein also interacts with other proteins like CYP3A4 which is involved in the metabolism of many drugs. These interactions affect the concentration and distribution of therapeutic agents contributing to the body's overall drug response.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Advanced healthcare materials 11:e2201178 PubMed35668035
2022
Applications
Unspecified application
Species
Unspecified reactive species
Analytical and bioanalytical chemistry 413:2021-2031 PubMed33528601
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 20:3883-3892 PubMed31485616
2019
Applications
Unspecified application
Species
Unspecified reactive species
Blood cancer journal 9:51 PubMed31113932
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 10:1981 PubMed31040273
2019
Applications
Unspecified application
Species
Unspecified reactive species
Drug delivery 26:443-458 PubMed30929529
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecules (Basel, Switzerland) 23: PubMed29534440
2018
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 8:66033-66050 PubMed29029490
2017
Applications
Unspecified application
Species
Unspecified reactive species
Biochemical pharmacology 85:1257-68 PubMed23415901
2013
Applications
Unspecified application
Species
Unspecified reactive species
Blood 80:2735-9 PubMed1360267
1992
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com